ClinicalTrials HQ

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

Recruiting · NCT06957366 · Registry updated 2025-05-09
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive ProcedureArrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorderRecruitingNot applicable2025-05-09NCT06957366

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
McMaster University202

14 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Brigham and Woman's HospitalBostonUnited States3
Hartford Health CareHartfordUnited States1
Henry Ford Health CareDetroitUnited States1
JuravinskiHamiltonCanada1
L'Hospital MontfortOttawaCanada1
North Shore University HealthEvanstonUnited States1
Northwell Health SystemNew YorkUnited States1
St. Joesph's HealthcareHamiltonCanada2
The Ottawa HospitalOttawaCanada47
Thomas Jefferson University HospitalPhiladelphiaUnited States271
Toronto General HospitalTorontoCanada8
University of LeuvenLeuvenBelgium1
University of ThessalyLarissaGreece1
Winnipeg Health Sciences CenterWinnipegCanada1